0001104659-23-033376.txt : 20230316 0001104659-23-033376.hdr.sgml : 20230316 20230316171659 ACCESSION NUMBER: 0001104659-23-033376 CONFORMED SUBMISSION TYPE: 15-12G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230316 DATE AS OF CHANGE: 20230316 EFFECTIVENESS DATE: 20230316 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Summit Healthcare Acquisition Corp. CENTRAL INDEX KEY: 0001839185 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 15-12G SEC ACT: 1934 Act SEC FILE NUMBER: 001-40466 FILM NUMBER: 23739811 BUSINESS ADDRESS: STREET 1: UGLAND HOUSE, BOX 309 CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1104 BUSINESS PHONE: 212-446-4800 MAIL ADDRESS: STREET 1: UGLAND HOUSE, BOX 309 CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1104 15-12G 1 tm239524d3_1512g.htm FORM 15-12G

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 15

 

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION

UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934.

 

Commission File Number 001-40466

 

 

SUMMIT HEALTHCARE ACQUISITION CORP.

 

(Exact name of registrant as specified in its charter)

 

 

Unit 1101, 11th Floor

1 Lyndhurst Tower, 1 Lyndhurst Terrace

Central, Hong Kong

+852-2155-7212

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Units, each consisting of one Class A ordinary share, par value $0.0001 per share, and one-half of one redeemable warrant

Class A ordinary shares, par value $0.0001 per share, included as part of the units

Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50

(Title of each class of securities covered by this Form)

 

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1)   x
Rule 12g-4(a)(2)   ¨
Rule 12h-3(b)(1)(i)   x
Rule 12h-3(b)(1)(ii)   ¨
Rule 15d-6   ¨
Rule 15d-22(b)   ¨

 

Approximate number of holders of record as of the certification or notice date: 1

 

 

 

 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, Summit Healthcare Acquisition Corp. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

  

        SUMMIT HEALTHCARE ACQUISITION CORP.
Dated: March 16, 2023        
       
        By: /s/ Yi Zhang
          Yi Zhang
          Director